Your browser doesn't support javascript.
loading
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
Jin, Zhi-Cheng; Zhong, Bin-Yan; Chen, Jian-Jian; Zhu, Hai-Dong; Sun, Jun-Hui; Yin, Guo-Wen; Ge, Nai-Jian; Luo, Biao; Ding, Wen-Bin; Li, Wen-Hui; Chen, Li; Wang, Yu-Qing; Zhu, Xiao-Li; Yang, Wei-Zhu; Li, Hai-Liang; Teng, Gao-Jun.
Affiliation
  • Jin ZC; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Zhong BY; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China.
  • Chen JJ; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Zhu HD; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Sun JH; Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Yin GW; Department of Interventional Radiology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Ge NJ; Department of Interventional Radiology, Eastern Hospital of Hepatobiliary Surgery, Second Military Medical University, Shanghai, 200438, China.
  • Luo B; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Ding WB; Department of Interventional Radiology, Nantong First People's Hospital, Nantong, 226001, China.
  • Li WH; Department of Interventional Radiology, Yancheng Third People's Hospital, Yancheng, 224008, China.
  • Chen L; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Wang YQ; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Zhu XL; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China. zhuxiaoli90@163.com.
  • Yang WZ; Department of Interventional Radiology, Union Hospital of Fujian Medical University, Fuzhou, 350001, China. ywzjn2012@163.com.
  • Li HL; Department of Minimally Invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China. cjr.lihailiang@vip.163.com.
  • Teng GJ; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China. gjteng@vip.sina.com.
Eur Radiol ; 33(12): 8669-8681, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37368105
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Radiol Journal subject: RADIOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Radiol Journal subject: RADIOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: